Philip Morris International (NY:PM)

187.46 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Philip Morris International

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

54 55 Next >

Philip Morris International to Host Webcast of 2024 Fourth-Quarter and Full-Year Results

January 30, 2025

From Philip Morris International

Via Business Wire

I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One. ↗

January 28, 2025

Via The Motley Fool

Q3 Rundown: Keurig Dr Pepper (NASDAQ:KDP) Vs Other Beverages, Alcohol, and Tobacco Stocks

January 28, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Keurig Dr Pepper (NASDAQ:KDP) and its peers.

Via StockStory

Topics Cannabis

A Once-in-a-Decade Opportunity: Buy This Magnificent Dividend Stock With a 4.2% Yield in 2025 and "Never" Sell ↗

January 27, 2025

Via The Motley Fool

Q3 Earnings Highlights: PepsiCo (NASDAQ:PEP) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks

January 27, 2025

Let’s dig into the relative performance of PepsiCo (NASDAQ:PEP) and its peers as we unravel the now-completed Q3 beverages, alcohol, and tobacco earnings season.

Via StockStory

Topics Cannabis

(PM) - Analyzing Philip Morris Intl's Short Interest ↗

January 10, 2025

Via Benzinga

Looking Into Philip Morris Intl's Recent Short Interest ↗

November 22, 2024

Via Benzinga

4 Soaring Stocks I'd Buy Now With No Hesitation ↗

January 25, 2025

Via The Motley Fool

TikTok Chat, Big Bank Review, and Some Stocks Worth Watching ↗

January 22, 2025

Via The Motley Fool

Multinational Survey by Philip Morris International Demonstrates Need for Greater Collaboration to Advance Innovation

January 22, 2025

From Philip Morris International

Via Business Wire

ZYN Nicotine Pouches Receive FDA Marketing Approval ↗

January 17, 2025

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products meet...

Via Benzinga

Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat ↗

January 17, 2025

According to the agency, the pouches could even benefit cigarette smokers by helping them quit.

Via Stocktwits

FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.

January 16, 2025

From Philip Morris International

Via Business Wire

This Philip Morris International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

January 16, 2025

Via Benzinga

3 Reasons to Buy British American Tobacco Stock Like There's No Tomorrow ↗

January 11, 2025

Via The Motley Fool

3 Must-Have Dividend Kings for 2025

January 06, 2025

While individual opportunities for strong share appreciation remain, a fresh focus area for 2025 might be dividend-paying stocks.

Via MarketBeat

Topics Economy

3 Top Dividend Stocks to Buy in 2025 With $200 ↗

January 04, 2025

Via The Motley Fool

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500? ↗

December 20, 2024

Curious about top-paying dividends in the S&P 500? Let's see if a modified "Dogs of the Dow" approach can find any long-term winners today.

Via The Motley Fool

Topics Stocks

Consumer Staples Select Sector SPDR Fund (XLP): Investing in Essential Goods

December 17, 2024

Consumer Staples Select Sector SPDR Fund (XLP): Investing in Essential Goods

Via News Direct

Topics Economy

Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share

December 12, 2024

From Philip Morris International

Via Business Wire

Billionaire Stanley Druckenmiller Sold 95% of Duquesne's Stake in Palantir and Is Piling Into This High-Yield Dividend Stock Instead ↗

December 04, 2024

Druckenmiller nearly exited his fund's position in one of Wall Street's hottest artificial intelligence (AI) stocks to buy a sizable stake in a boring company with exceptional pricing power.

Via The Motley Fool

Topics Artificial Intelligence

Best Stock to Buy Right Now: Altria vs. British American Tobacco ↗

November 28, 2024

Via The Motley Fool

Philip Morris International Marks a Decade of IQOS—a Milestone in the Journey to a Smoke-Free Future

November 27, 2024

From Philip Morris International

Via Business Wire

Billionaires Are Buying Up This Millionaire-Maker Stock ↗

November 24, 2024

Via The Motley Fool

3 Supercharged Growth Stocks That Billionaires Are Buying ↗

November 23, 2024

Via The Motley Fool

Walmart's Flywheel Keeps Spinning ↗

November 22, 2024

We also look at nicotine products' popularity.

Via The Motley Fool

Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex' ↗

November 21, 2024

As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed...

Via Benzinga

Topics Government World Trade

2 High-Yield Dividend Stocks I Can't Stop Buying ↗

November 18, 2024

Via The Motley Fool

3 High-Yields Unfazed by the Election: Altria, Truist, Verizon

November 15, 2024

TFC, MO, and VZ offer high dividend yields, providing stability for income-focused investors amid extreme market moves, market volatility, and uncertainty.

Via MarketBeat

Topics Cannabis

Top Research Reports for JPMorgan, Philip Morris & Progressive ↗

November 14, 2024

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Philip Morris International Inc. (PM) and The Progressive Corp. (PGR).

Via Talk Markets

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

54 55 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.